If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)
Humalog® Therapies
Humalog® U-100 (insulin lispro injection)
100 units/mLHumalog® U-200 (insulin lispro injection)
200 units/mLHumalog® MIX50/50™ (50% insulin lispro protamine suspension 50% insulin lispro injection [rDNA origin])
100 units/mLHumalog® MIX75/25™ (75% insulin lispro protamine suspension 25% insulin lispro injection [rDNA origin])
100 units/mLThis information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
Is dose conversion needed when transitioning to the Humalog® (insulin lispro) 200 units/mL KwikPen® from the Humalog® (insulin lispro) 100 units/mL?
When transitioning from Humalog 100 units/mL to Humalog 200 units/mL, no dose conversion is needed.
Dose Conversion
Do NOT perform dose conversion when using the Humalog® (insulin lispro injection) 200 units/mL KwikPen® (pen).1
The dose window shows the number of insulin units to be delivered and no conversion is needed.1
Therefore, a patient receiving 20 units of Humalog® (insulin lispro injection) 100 units/mL and transitioning to the Humalog 200 units/mL pen should dial the pen to 20 units to administer the same 20-unit dose of insulin lispro.2
Enclosed Prescribing Information
References
1Humalog [package insert]. Indianapolis, IN: Eli Lilly and Company; 2019.
2Data on file, Eli Lilly and Company and/or one of its subsidiaries.
Date of Last Review: June 15, 2022